Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRodriguez Losada, Olalla
dc.contributor.authorMontaner Ramón, Alicia
dc.contributor.authorGregoraci Fernández, Angela
dc.contributor.authorFlores España, Vanessa
dc.contributor.authorTurpin, Anna Gros
dc.contributor.authorComuñas Gómez, Juan José
dc.contributor.authorCastillo Salinas, Félix
dc.date.accessioned2022-09-09T09:39:26Z
dc.date.available2022-09-09T09:39:26Z
dc.date.issued2022-04
dc.identifier.citationLosada OR, Ramón AM, Fernández AG, España VF, Turpin AG, Gómez JJC, et al. Use of high flow nasal cannula in Spanish neonatal units. An Pediatría (English Ed). 2022 Apr;96(4):319–25.
dc.identifier.issn2341-2879
dc.identifier.urihttp://hdl.handle.net/11351/8104
dc.descriptionNeonate; Respiratory therapy; Survey
dc.description.abstractIntroduction The use of high-flow cannula therapy (HFNC) in neonatal units has increased in recent years, but there are no consensus guidelines on its indications and application strategies. Our aim was to know the rate of use of HFNC, their indications and the management variability among Spanish neonatal units. Material and methods Twenty-five-question survey for medical and nursing staff. Level II and III units were contacted by phone and sent in Google forms between September 2016 and December 2018. Results Ninety-seven responses (63.9% medical, 36.1% nursing), from 69 neonatal units representing 15 autonomous communities (87% level of care III; 13% level II). All units except one have HFNC with a humidified and heated system. Their most frequent indications are: non-invasive ventilation weaning (79.4%), bronchiolitis (69.1%), respiratory distress of the term newborn (58.8%), after extubation (50.5%). Minimum flow (1–5 L/min) and maximum flow (5–15 L/min) are variable between units. 22.7% have experienced some adverse effect from its use (9 air leak, 12 nasal trauma). Less than half have an employment protocol, but all the answers agree on the usefulness of national recommendations. Conclusions HFNC therapy is widely used in Spanish units, but there is great variability in its indications and strategies of use. National recommendations would be applicable in most units and would allow unifying its use.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesAnales de Pediatría (English Edition);96(4)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectInfants nadons
dc.subjectOxigenoteràpia
dc.subjectEnquestes
dc.subject.meshInfant, Newborn
dc.subject.meshOxygen Inhalation Therapy
dc.subject.meshSurveys and Questionnaires
dc.titleUse of high flow nasal cannula in Spanish neonatal units
dc.title.alternativeUtilización de las cánulas nasales de alto flujo en las unidades neonatales españolas
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.anpede.2021.02.015
dc.subject.decsrecién nacido
dc.subject.decstratamiento por inhalación de oxígeno
dc.subject.decsencuestas y cuestionarios
dc.relation.publishversionhttps://doi.org/10.1016/j.anpede.2021.02.015
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Losada OR, Ramón AM, España VF, Turpin AG, Gómez JJC, Salinas FC] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gregoraci Fernández A] Hospital Universitario Dr. Josep Trueta, Girona, Spain
dc.identifier.pmid35523688
dc.identifier.wos000802871000006
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record